Opthea Analysis
| OPTDelisted Stock | USD 3.41 0.07 2.01% |
Opthea's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Opthea's financial risk is the risk to Opthea stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Opthea's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Opthea is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Opthea to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Opthea is said to be less leveraged. If creditors hold a majority of Opthea's assets, the Company is said to be highly leveraged.
Opthea is fairly valued with Real Value of 3.36 and Hype Value of 3.41. The main objective of Opthea delisted stock analysis is to determine its intrinsic value, which is an estimate of what Opthea is worth, separate from its market price. There are two main types of Opthea's stock analysis: fundamental analysis and technical analysis.
The Opthea stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Opthea is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Opthea Stock trading window is adjusted to America/New York timezone.
Opthea |
Opthea Stock Analysis Notes
The company recorded a loss per share of 2.25. Opthea had not issued any dividends in recent years. The entity had 5:8 split on the 15th of October 2020. Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia. Opthea operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. To find out more about Opthea contact MAICD MAICD at 61 3 9826 0399 or learn more at https://opthea.com.Opthea Investment Alerts
| Opthea is not yet fully synchronised with the market data | |
| Opthea has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 124.67 K. Reported Net Loss for the year was (220.24 M) with profit before taxes, overhead, and interest of 208.86 K. | |
| Opthea has about 44.63 M in cash with (161.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01. |
Opthea Market Capitalization
The company currently falls under 'Small-Cap' category with a total capitalization of 524.82 M.Opthea Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Opthea insiders, such as employees or executives, is commonly permitted as long as it does not rely on Opthea's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Opthea insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Opthea Outstanding Bonds
Opthea issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Opthea uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Opthea bonds can be classified according to their maturity, which is the date when Opthea has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| ORACLE P 5375 Corp BondUS68389XAM74 | View | |
| ORACLE P 6125 Corp BondUS68389XAH89 | View | |
| ORACLE P 65 Corp BondUS68389XAE58 | View | |
| ORACLE PORATION Corp BondUS68389XBU81 | View | |
| ORACLE P 325 Corp BondUS68389XBN49 | View | |
| ORACLE P 265 Corp BondUS68389XBM65 | View | |
| ORACLE P 38 Corp BondUS68389XBP96 | View | |
| ORACLE P 4 Corp BondUS68389XBQ79 | View |
Opthea Predictive Daily Indicators
Opthea intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Opthea stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Opthea Debt to Cash Allocation
Opthea has 141.65 M in debt. Opthea has a current ratio of 4.87, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Opthea to invest in growth at high rates of return.Opthea Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Opthea's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Opthea, which in turn will lower the firm's financial flexibility.Opthea Corporate Bonds Issued
About Opthea Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Opthea prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Opthea shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Opthea. By using and applying Opthea Stock analysis, traders can create a robust methodology for identifying Opthea entry and exit points for their positions.
Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia. Opthea operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Opthea to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Opthea Stock
If you are still planning to invest in Opthea check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Opthea's history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |